Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renguo Guan

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Annals of Translational Medicine|November 18, 2021
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomyWuzheng Xia, Tianyi Peng, Renguo Guan, et al.
Cancer Management and Research|May 24, 2019
Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysisMin Yu, Renguo Guan, Weifeng Hong, et al.
Journal of Oncology|April 11, 2022
Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive ManagementZehao Zheng, Renguo Guan, Wang Jianxi, et al.
Aging|July 28, 2020
The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinomaYe Lin, Haosheng Jin, Xianqiu Wu, et al.
International Journal of Cancer|November 14, 2019
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survivalLei Tu, Renguo Guan, Hanting Yang, et al.
Molecular Medicine (Cambridge, Mass.)|February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinomaMin Deng, Shiquan Sun, Rongce Zhao, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapyZehao Zheng, Jie Mei, Renguo Guan, et al.
Journal of Hepatocellular Carcinoma|April 10, 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching AnalysisYuhua Wen, Lianghe Lu, Jie Mei, et al.
Acta Biomaterialia|November 19, 2015
An in vivo study on the metabolism and osteogenic activity of bioabsorbable Mg-1Sr alloyDi Tie, Renguo Guan, Huinan Liu, et al.
International Immunopharmacology|July 1, 2024
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patientsJie Mei, Chengyou Yu, Feng Shi, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Annals of Translational Medicine|November 18, 2021
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomyWuzheng Xia, Tianyi Peng, Renguo Guan, et al.
Cancer Management and Research|May 24, 2019
Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysisMin Yu, Renguo Guan, Weifeng Hong, et al.
Journal of Oncology|April 11, 2022
Microvascular Invasion in Hepatocellular Carcinoma: A Review of Its Definition, Clinical Significance, and Comprehensive ManagementZehao Zheng, Renguo Guan, Wang Jianxi, et al.
Aging|July 28, 2020
The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinomaYe Lin, Haosheng Jin, Xianqiu Wu, et al.
International Journal of Cancer|November 14, 2019
Assessment of the expression of the immune checkpoint molecules PD-1, CTLA4, TIM-3 and LAG-3 across different cancers in relation to treatment response, tumor-infiltrating immune cells and survivalLei Tu, Renguo Guan, Hanting Yang, et al.
Molecular Medicine (Cambridge, Mass.)|February 6, 2022
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinomaMin Deng, Shiquan Sun, Rongce Zhao, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2024
A novel liver-function-indicators-based prognosis signature for patients with hepatocellular carcinoma treated with anti-programmed cell death-1 therapyZehao Zheng, Jie Mei, Renguo Guan, et al.
Journal of Hepatocellular Carcinoma|April 10, 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching AnalysisYuhua Wen, Lianghe Lu, Jie Mei, et al.
Acta Biomaterialia|November 19, 2015
An in vivo study on the metabolism and osteogenic activity of bioabsorbable Mg-1Sr alloyDi Tie, Renguo Guan, Huinan Liu, et al.
International Immunopharmacology|July 1, 2024
The ARH score, a practical guide to decision-making for retreatment with hepatic arterial infusion chemotherapy in hepatocellular carcinoma patientsJie Mei, Chengyou Yu, Feng Shi, et al.
Pageof 6